Aytu Biopharma (AYTU) Consolidated Net Income (2010 - 2026)
Aytu Biopharma (AYTU) reported Consolidated Net Income of -$15,000 for fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with -$19.82 million a year earlier.
Powered by 
Analysis
Aytu Biopharma (AYTU) Consolidated Net Income (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Aytu Biopharma posted Consolidated Net Income of -$14.25 million.
- By fiscal year, Consolidated Net Income came in at -$13.56 million in FY2025, -$15.84 million in FY2024, -$17.05 million in FY2023 and -$108.78 million in FY2022.
- Five-year quarterly Consolidated Net Income spans a low of -$53.29 million in fiscal Q3 2022 and a high of $3.99 million in fiscal Q3 2025.
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at -$5.62 million (Q3 2026), -$10.58 million (Q2 2026) and $1.97 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Aytu Biopharma | 22.49 Mn | -93.18 Mn | 10.41 Mn | -15,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15,000.00 |
| Mar 31, 2026 | -5.62 Mn |
| Dec 31, 2025 | -10.58 Mn |
| Sep 30, 2025 | 1.97 Mn |
| Jun 30, 2025 | -19.82 Mn |
| Mar 31, 2025 | 3.99 Mn |
| Dec 31, 2024 | 788,000.00 |
| Sep 30, 2024 | 1.47 Mn |
| Jun 30, 2024 | -4.62 Mn |
| Mar 31, 2024 | -2.89 Mn |
| Dec 31, 2023 | -220,000.00 |
| Sep 30, 2023 | -8.12 Mn |
| Jun 30, 2023 | -2.46 Mn |
| Mar 31, 2023 | -7.20 Mn |
| Dec 31, 2022 | -6.69 Mn |
| Sep 30, 2022 | -701,000.00 |
| Jun 30, 2022 | -16.09 Mn |
| Mar 31, 2022 | -53.29 Mn |
| Dec 31, 2021 | -11.55 Mn |
| Sep 30, 2021 | -27.85 Mn |
API Access
Aytu Biopharma Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();